10.1146/annurev.neuro.27.070203.144244 [DOI] [PubMed] [Google Scholar] Buck E., Bayer H., Lindenberg K
The combination of BPC-157 and TB-500 has become especially popular in regenerative medicine circles because both peptides are commonly associated with tissue repair and recovery support
You can see if you qualify for a personalized program from home
Established risk factors for venous thromboembolism (VTE) include: Obesity (BMI 30 kg/m), which increases venous stasis and pro-inflammatory states Immobility or reduced mobility , particularly relevant in patients with severe obesity Previous history of VTE or family history of thrombophilia Active malignancy or recent surgery Hormonal therapies , including combined oral contraceptives or hormone replacement therapy Pregnancy and the postpartum period Smoking , which affects endothelial function and coagulation Risk factors for arterial thrombosis (myocardial infarction, stroke) include: Type 2 diabetes mellitus , associated with endothelial dysfunction, platelet hyperreactivity, and a prothrombotic state Hypertension , causing arterial wall damage Dyslipidaemia , promoting atherosclerotic plaque formation Established cardiovascular disease Chronic kidney disease , common in diabetes and associated with increased cardiovascular risk Patients initiating GLP-1 therapy should undergo a comprehensive cardiovascular risk assessment
Yu J, Mei J, Zuo D, Zhang M, Yu S, Li F, et al
